The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics
- 29 August 2012
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 92 (4), 446-449
- https://doi.org/10.1038/clpt.2012.117
Abstract
The paradigm of individualized drug therapy based on genetics is an ideal that is now potentially possible. However, translation of pharmacogenomics into practice has encountered barriers such as limited availability and the high cost of genetic testing, the delays involved, disagreements about interpretation of results, and even lack of understanding about pharmacogenomics in general. We describe our institutional pharmacogenomics‐implementation project, “The 1200 Patients Project,” a model designed to overcome these barriers and facilitate the availability of pharmacogenomic information for personalized prescribing. Clinical Pharmacology & Therapeutics (2012); 92 4, 446–449. doi:10.1038/clpt.2012.117Keywords
This publication has 4 references indexed in Scilit:
- Company Profile: Sequenom, Inc.Pharmacogenomics, 2012
- Pharmacogenomics: “Noninferiority” Is Sufficient for Initial ImplementationClinical Pharmacology & Therapeutics, 2011
- Personalized Medicine: Building the GPS to Take Us ThereClinical Pharmacology & Therapeutics, 2007
- Changing Physicians' PracticesNew England Journal of Medicine, 1993